NMN (Nicotinamide Mononucleotide) is officially reinstated as a lawful dietary supplement after the FDA’s September 2025 reversal, ending years of regulatory uncertainty. This decision restores access to this key NAD+ precursor and validates its use in custom formulations. The FDA reversed its 2022 action that had classified NMN as a drug candidate. Evidence showed NMN…
Spore-based probiotics are transforming the custom dietary supplement industry with their resilience, targeted efficacy, and customization potential. For healthcare practitioners, spore-based probiotics offer unmatched flexibility and reliability in personalized formulations empowering them to deliver targeted, science-backed solutions that align with each patient’s unique biochemistry. Partnering with Personalized Nutrients ensures access to high-quality strains, rigorous testing,…